Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Bismuth Quadruple Therapy in the Second Line and Third Line Therapy for Helicobacter Pylori Infection- A Multi-center Randomized Trial

NCT03148366 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03148366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03148366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Bismuth Quadruple Therapy in the Second Line and Third Line Therapy for Helicobacter Pylori Infection- A Multi-center Randomized Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
December 31, 2020
Enrollment
560 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter